RBOT
Vicarious Surgical Inc.NYSEHealthcare$0.73+6.67%ClosedMarket Cap: $4.7M
As of 2026-04-04
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.54
P/S
0.00
EV/EBITDA
-0.21
DCF Value
$-1.02
FCF Yield
-872.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-247.6%
ROA
-256.3%
ROIC
-289.1%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $0.00 | $-10.5M | $-1.57 |
| FY 2025 | $0.00 | $-50.2M | $-8.45 |
| Q3 2025 | $0.00 | $-11.1M | $-1.86 |
| Q2 2025 | $0.00 | $-13.2M | $-2.23 |
Trading Activity
Insider Trades
View AllSachs Adam Daviddirector, officer: President
SellTue Feb 24
Khalifa Sammydirector, officer: Chief Technology Officer
SellTue Feb 24
Sachs Adam Daviddirector, 10 percent owner, officer: President
SellThu Dec 04
Khalifa Sammydirector, 10 percent owner, officer: Chief Technology Officer
SellThu Dec 04
Khalifa Sammydirector, 10 percent owner, officer: Chief Technology Officer
SellFri Nov 21
Company Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NYSE
Beta
1.55
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.